"Catapult Your Business to Fore, Gain Competitive Advantage "

Pleural Effusion Treatment Market Size, Share and Global Trend By Type (Transudate Effusion, Exudate Effusion), By Treatment (Quantitative Test Chest Draining, Pleurodesis, Thoracentesis, Pleuroperitoneal shunt, Catheter), By End User(Hospitals, Clinics, Ambulatory Surgery Centers) and Geography Forecast till 2021-2028

Region : Global | Report ID: FBI100485 | Status : Ongoing

 

KEY MARKET INSIGHTS

Pleural effusion is an abnormal condition in which excess fluid is present in the layers of pleura outside the lungs. In a normal condition, a small amount of fluid is already present in pleura in order to smoothen the breathing process. The treatment of pleural effusion includes removal of excess water from the lungs and diagnosing the cause of accumulating excess water in the lung and treating it. Certain causes such as heart failure, lung cancer, breast cancer, cirrhosis, leukemia, pulmonary embolism, kidney disease, lung infections, and ruptured esophagus are responsible for pleural effusion. According to the Labor Force Survey, 18,000 new cases in the U.K. are diagnosed with lung or breathing problem every year. 


Rising prevalence of pleural effusion is a significant factor propelling the growth of the global pleural effusion treatment market. Also, the rising prevalence of lung injuries, lung tumors, congestive heart failure, and lymph or blood vessels blockages are further expected to expand the prevalence of pleural effusion. According to the European Society of Cardiology in 2014, an estimated 26 million people are suffering from heart failure worldwide. 

To gain extensive insights into the market, Request for Customization


However, increased risk of infection, bleeding and collapsed lung are restraining factors for the global pleural effusion treatment market. 


Key Players Covered 


Some of the major companies that are present in the global pleural effusion treatment market Pixelenergy, HEYER Medical AG, Biometrix, Redax, B. Braun Melsungen AG, OAKWORKS® Medical, Bıçakcılar Medical Equipment AS, Smiths Medical and others.  and others. 


SEGMENTATION 


























 SEGMENTATION



 DETAILS



By Type



·         Transudate Effusion


·         Exudate Effusion



By Treatment



·         Quantitative Test Chest Draining


·         Pleurodesis


·         Thoracentesis


·         Pleuroperitoneal shunt


·         Catheter


·         Others



By End User



·         Hospitals


·         Clinics


·         Ambulatory Surgery Centers


·         Others



By Geography



·         North America (USA and Canada)


·         Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


·         Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


·         Latin America (Brazil, Mexico and Rest of Latin America)


·         Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



                               


In 2018, exculpate effusion accounted for the highest share in the type segment in the global pleural effusion treatment market due to an increased number of hepatitis and other viral borne diseases. The segment is projected to continue its dominance in the market share during the forecast period. 


Key Insights 



  • Pricing Analysis by Key Regions

  • Reimbursement Scenario for key countries

  • Recent industry developments such as partnerships, mergers, and acquisitions 

Regional Analysis 


North America dominated the global pleural effusion treatment market in 2018, owing to rising prevalence of pleural effusion as well as heart-related diseases. According to the National Cancer Institute, an estimated 100,000 new cases are diagnosed with pleural effusion in the U.S. each year. According to Centers for Disease Control and Prevention, in 2016, 4.9 million people were suffering from chronic liver disease and cirrhosis in the U.S. Asia Pacific is anticipated to grow at a significant CAGR during the forecast period of 2019-2026, owing to rising prevalence of pleural effusion. 


Key Industry Developments     




  • In April 2019, University of California, Los Angeles updated the progress and positive results of the studies of the tunneled pleural catheters for refractory effusions attributed to congestive heart failure (TREAT-CHF) TRIAL (TREAT-CHF).
  • In January 2017, BD received U.S. Food and Drug Administration for the PleurX catheter system received for the use in specific non-malignant recurrent pleural effusions etiologies, including congestive heart failure.

Pleural Effusion Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X